BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3324711)

  • 1. The pathophysiological role of renal dopamine, kallikrein kinin and prostaglandin systems in essential hypertension.
    Iimura O; Shimamoto K; Ura N; Nakagawa M; Nishimiya T; Ando T; Yamaguchi Y; Masuda A; Ogata H; Saito S
    Agents Actions Suppl; 1987; 22():247-56. PubMed ID: 3324711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the renal kallikrein-kinin system in sodium metabolism in normal and low renin essential hypertension.
    Shimamoto K; Nakao T; Ura N; Tanaka S; Ando T; Nishimiya T; Mita T; Kondo M; Nakagawa M; Iimura O
    Jpn Circ J; 1983 Oct; 47(10):1210-5. PubMed ID: 6355550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal kallikrein-kinin, prostaglandin E2, and dopamine systems in young normotensive subjects with a family history of essential hypertension.
    Shimamoto K; Ura N; Nishimura M; Iimura O
    Am J Med Sci; 1994 Feb; 307 Suppl 1():S70-4. PubMed ID: 8141169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of renal kallikrein-kinin system and prostaglandins in diuresis and natriuresis following saline infusion in normotensives and essential hypertensives.
    Nishimiya T; Shimamoto K; Tanaka S; Ura N; Mita T; Nakagawa M; Maeda T; Yamaguchi Y; Masuca A; Iimura O
    Adv Exp Med Biol; 1986; 198 Pt B():337-42. PubMed ID: 3643730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal kallikrein-kinin system and prostaglandin in hypertension: their relation to renin-angiotensin-aldosterone system.
    Abe K; Yasujima M; Chiba S; Sato M; Irokawa N; Imai Y; Yoshinaga K
    Adv Exp Med Biol; 1979; 120B():487-501. PubMed ID: 517244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypotensive and natriuretic effects of nifedipine in essential hypertension. Role of renal kallikrein-kinin-prostaglandin and renin-angiotensin-aldosterone systems.
    Tsunoda K; Abe K; Omata K; Kudo K; Sato M; Kohzuki M; Tanno M; Seino M; Yasujima M; Yoshinaga K
    J Clin Hypertens; 1986 Sep; 2(3):263-70. PubMed ID: 3640807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced activity of the kallikrein-kinin system predominates over renin-angiotensin system overactivity in all conditions of sodium balance in essential hypertensives and family-related hypertension.
    Sànchez R; Nolly H; Giannone C; Baglivo HP; Ramírez AJ
    J Hypertens; 2003 Feb; 21(2):411-7. PubMed ID: 12569273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salt and hypertension: water-sodium handling in essential hypertension.
    Iimura O; Shimamoto K
    Ann N Y Acad Sci; 1993 Mar; 676():105-21. PubMed ID: 8489125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A circadian variation in the excretion of urinary kinin, kallikrein and prostaglandin E in normal volunteers.
    Abe K; Sato M; Kasai Y; Haruyama T; Sato K; Miyazaki S; Imai Y; Hiwatari M; Itoh T; Sakurai Y; Goto T; Tajima J; Seino M; Yoshinaga K
    Jpn Circ J; 1981 Sep; 45(9):1098-103. PubMed ID: 7029030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake.
    Levy SB; Lilley JJ; Frigon RP; Stone RA
    J Clin Invest; 1977 Jul; 60(1):129-38. PubMed ID: 874078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of renal dopamine and kallikrein-kinin systems in antihypertensive mechanisms of exercise in rats.
    Maeda H; Sasaguri M; Sakai T; Kinoshita A; Koga M; Noda K; Tsuji E; Ideishi M; Arakawa K
    Hypertens Res; 2000 Sep; 23(5):511-9. PubMed ID: 11016807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Renal kallikrein-kinin system and control of blood pressure (author's transl)].
    Distler A; Wolff HP
    Klin Wochenschr; 1979 Oct; 57(19):1037-45. PubMed ID: 392177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of renal prostaglandins, kallikrein, vasopressin and aldosterone in essential hypertension.
    Favre L; Jornot L; Riondel A; Vallotton M
    Clin Exp Hypertens A; 1985-1986; 7(12):1663-79. PubMed ID: 3869481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of renal kallikrein in modulating the antihypertensive effect of a single oral dose of captopril in normal- and low-renin essential hypertensives.
    Madeddu P; Oppes M; Rubattu S; Dessi'-Fulgheri P; Glorioso N; Soro A; Rappelli A
    J Hypertens; 1987 Dec; 5(6):645-8. PubMed ID: 3323316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of kallikrein-kinin and renin-angiotensin systems in the hypotensive mechanism of angiotensin-I converting enzyme inhibitors in essential hypertensives.
    Iimura O; Shimamoto K
    Adv Exp Med Biol; 1989; 247A():39-48. PubMed ID: 2532450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal vasoactive hormones in scleroderma (progressive systemic sclerosis).
    Oliver JA; Vinci JM; Bowden RE; Weinberger AB; Baer L; Keiser HR; Cannon PJ
    Nephron; 1981; 29(3-4):110-6. PubMed ID: 7035981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary prostaglandin E2 and kallikrein excretion in glucocorticoid hypertension in rats.
    Handa M; Kondo K; Suzuki H; Saruta T
    Clin Sci (Lond); 1983 Jul; 65(1):37-42. PubMed ID: 6342908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-modulating hypertension: evidence for the involvement of kallikrein/kinin activity associated with overactivity of the renin-angiotensin system. Successful blood pressure control during long-term Na+ restriction.
    Sanchez R; Gimenez MI; Ramos F; Baglivo H; Ramirez AJ
    J Hypertens; 1996 Nov; 14(11):1287-91. PubMed ID: 8934356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interrelationships between the renal kallikrein-kinin and prostaglandin systems in furosemide-induced diuresis.
    Ayano Y; Yamasaki K; Soejima H; Ikegami K
    Urol Int; 1984; 39(1):52-7. PubMed ID: 6587655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The renal kallikrein-kinin system at the prehypertensive stage of hypertension.
    Shimamoto K; Iimura O
    Agents Actions Suppl; 1992; 38 ( Pt 3)():287-93. PubMed ID: 1462863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.